ArticleMedical oncology (Northwood, London, England)2006

Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14).

Magdalena Adde et al.PubMed ↗Publisher ↗

No numbers read from the abstract.